Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
JANX
Janux Therapeutics, Inc.
NASDAQ · Pharmaceutical Preparations
Last close
$17.28
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$1.06B
RECENT INSIDER TRADES
2026-07-10
· Campbell David Alan
(President and CEO)
· OTHER
2026-06-12
· DOBMEIER ERIC
(Director)
· OTHER
2026-06-12
· Hernday Natasha
(Director)
· OTHER
2026-06-12
· Kung Winston
(Director)
· OTHER
2026-06-12
· Barrett Ronald W
(Director)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
215
Shares held
71,111,820
Value
$1.14B
Percent of shares outstanding
116.32%
As of quarter end
2026-06-30
RECENT NEWS
Janux Therapeutics: It's Too Early To Tell If Prostate Cancer Program Can Succeed
Janux Therapeutics presents at Cantor Fitzgerald healthcare conference
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Janux Therapeutics, Inc. (JANX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit